MNPR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Monopar Therapeutics (MNPR).


$116.11M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

MNPR Market Cap. (MRY)


MNPR Shares Outstanding (MRY)


MNPR Assets (MRY)


Total Assets

$60.29M

Total Liabilities

$5.25M

Total Investments

$14.40M

MNPR Income (MRY)


Revenue

$0

Net Income

-$15.59M

Operating Expense

$16.16M

MNPR Cash Flow (MRY)


CF Operations

-$6.40M

CF Investing

-$14.34M

CF Financing

$59.29M

MNPR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MNPR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$60,291,071 (720.83%)

$7,345,159 (-44.47%)

$13,226,954 (-35.55%)

$20,521,614 (21.66%)

Assets Current

$60,291,071 (722.24%)

$7,332,513 (-44.31%)

$13,165,726 (-35.84%)

$20,521,614 (22.15%)

Assets Non-Current

$0 (0%)

$12,646 (-79.35%)

$61,228 (0%)

$0 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$55,036,771 (884.95%)

$5,587,766 (-44.62%)

$10,089,652 (-46.73%)

$18,941,071 (20.71%)

Property Plant & Equipment Net

$0 (0%)

$12,646 (-79.35%)

$61,228 (0%)

$0 (0%)

Cash & Equivalents

$45,816,289 (530.55%)

$7,266,080 (-11.24%)

$8,186,194 (-59.68%)

$20,303,869 (21.31%)

Accumulated Other Comprehensive Income

$35,992 (354.68%)

-$14,132 (-258.04%)

$8,942 (382.97%)

-$3,160 (59.86%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$14,395,913 (0%)

$0 (0%)

$4,933,550 (0%)

$0 (0%)

Investments Current

$14,395,913 (0%)

$0 (0%)

$4,933,550 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,254,300 (28.28%)

$1,757,393 (-43.83%)

$3,128,894 (97.96%)

$1,580,543 (34.32%)

Accumulated Retained Earnings (Deficit)

-$75,792,636 (-25.89%)

-$60,206,217 (-16.22%)

-$51,804,021 (-25.47%)

-$41,288,383 (-28.28%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$8,408 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$8,408 (0%)

$0 (0%)

Total Liabilities

$5,254,300 (198.98%)

$1,757,393 (-43.98%)

$3,137,302 (98.50%)

$1,580,543 (34.32%)

Liabilities Current

$5,254,300 (198.98%)

$1,757,393 (-43.83%)

$3,128,894 (97.96%)

$1,580,543 (34.32%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$8,408 (0%)

$0 (0%)

MNPR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$3,155,735 (-2.33%)

$3,231,042 (9.70%)

$2,945,276 (11.82%)

$2,634,040 (7.79%)

Research & Development Expense

$13,005,986 (132.24%)

$5,600,193 (-26.23%)

$7,591,601 (16.92%)

$6,493,208 (59.73%)

Operating Expenses

$16,161,721 (83.01%)

$8,831,235 (-16.19%)

$10,536,877 (15.44%)

$9,127,248 (40.23%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$15,586,419 (-85.50%)

-$8,402,196 (20.10%)

-$10,515,638 (-15.52%)

-$9,103,224 (-44.39%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$15,586,419 (-85.50%)

-$8,402,196 (20.10%)

-$10,515,638 (-15.52%)

-$9,103,224 (-44.39%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$15,586,419 (-85.50%)

-$8,402,196 (20.10%)

-$10,515,638 (-15.52%)

-$9,103,224 (-44.39%)

Weighted Average Shares

$3,790,202 (-72.58%)

$13,823,951 (8.69%)

$12,718,166 (1.98%)

$12,471,217 (13.81%)

Weighted Average Shares Diluted

$3,790,202 (-72.58%)

$13,823,951 (8.69%)

$12,718,166 (1.98%)

$12,471,217 (13.81%)

Earning Before Interest & Taxes (EBIT)

-$15,586,419 (-85.50%)

-$8,402,196 (20.10%)

-$10,515,638 (-15.52%)

-$9,103,224 (-44.39%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$16,161,721 (-83.01%)

-$8,831,235 (16.19%)

-$10,536,877 (-15.44%)

-$9,127,248 (-40.23%)

MNPR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$14,338,403 (-390.97%)

$4,927,748 (200.19%)

-$4,918,511 (0%)

$0 (0%)

Net Cash Flow from Financing

$59,292,257 (2824.80%)

$2,027,227 (6066.85%)

$32,873 (-99.70%)

$10,879,537 (32.97%)

Net Cash Flow from Operations

-$6,404,139 (18.50%)

-$7,858,293 (-8.71%)

-$7,228,559 (1.21%)

-$7,317,401 (-56.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

$38,550,209 (4289.72%)

-$920,114 (92.41%)

-$12,117,675 (-439.74%)

$3,566,760 (1.24%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$14,338,403 (-390.97%)

$4,927,748 (200.19%)

-$4,918,511 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$59,396,477 (2763.59%)

$2,074,196 (1794.14%)

$109,506 (-99.00%)

$10,942,790 (33.85%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$494 (102.94%)

-$16,796 (-382.92%)

-$3,478 (-175.22%)

$4,624 (38.69%)

Share Based Compensation

$1,140,785 (-39.89%)

$1,897,849 (15.63%)

$1,641,263 (11.80%)

$1,468,054 (11.14%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

MNPR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-84.80% (26.90%)

-116.00% (-49.10%)

-77.80% (-89.29%)

-41.10% (5.95%)

Return on Average Assets (ROAA)

-75.60% (14.29%)

-88.20% (-31.05%)

-67.30% (-72.56%)

-39.00% (6.25%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-800.60% (22.37%)

-1031.30% (-161.94%)

1664.90% (82.39%)

912.80% (-36.65%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-5.35 (-859.32%)

-0.56 (80.46%)

-2.85 (35.07%)

-4.4 (58.33%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

2.11 (133.15%)

0.91 (-70.03%)

3.02 (41.52%)

2.13 (-52.22%)

Debt to Equity Ratio (D/E)

0.1 (-69.84%)

0.32 (1.29%)

0.31 (274.70%)

0.08 (10.67%)

Earnings Per Share (EPS)

-4.11 (-573.77%)

-0.61 (26.51%)

-0.83 (-13.70%)

-0.73 (-25.86%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.69 (-197.54%)

-0.57 (0.00%)

-0.57 (3.24%)

-0.59 (-38.12%)

Book Value Per Share (BVPS)

14.52 (3494.31%)

0.4 (-49.05%)

0.79 (-47.79%)

1.52 (6.08%)

Tangible Assets Book Value Per Share (TABVPS)

15.91 (2895.67%)

0.53 (-48.94%)

1.04 (-36.82%)

1.65 (6.95%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (0%)

0 (0%)

-2 (0.00%)

-2 (75.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-7.06 (-13179.63%)

0.05 (103.51%)

-1.54 (22.52%)

-1.99 (76.04%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

11.47 (175.05%)

4.17 (-0.86%)

4.21 (-67.59%)

12.98 (-9.06%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$6,404,139 (18.50%)

-$7,858,293 (-8.71%)

-$7,228,559 (1.21%)

-$7,317,401 (-56.95%)

Enterprise Value (EV)

$110,091,428 (24147.72%)

-$457,804 (-102.83%)

$16,172,481 (-10.52%)

$18,074,301 (-65.39%)

Earnings Before Tax (EBT)

-$15,586,419 (-85.50%)

-$8,402,196 (20.10%)

-$10,515,638 (-15.52%)

-$9,103,224 (-44.39%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$15,586,419 (-85.50%)

-$8,402,196 (20.10%)

-$10,515,638 (-15.52%)

-$9,103,224 (-44.39%)

Invested Capital

$9,220,482 (649.39%)

-$1,678,314 (-187.40%)

$1,920,274 (240.91%)

-$1,362,798 (-30.40%)

Working Capital

$55,036,771 (887.19%)

$5,575,120 (-44.45%)

$10,036,832 (-47.01%)

$18,941,071 (21.24%)

Tangible Asset Value

$60,291,071 (720.83%)

$7,345,159 (-44.47%)

$13,226,954 (-35.55%)

$20,521,614 (21.66%)

Market Capitalization

$116,111,512 (2195.81%)

$5,057,549 (-83.40%)

$30,468,092 (-24.61%)

$40,415,865 (-42.33%)

Average Equity

$18,387,755 (153.79%)

$7,245,135 (-46.42%)

$13,520,871 (-39.01%)

$22,168,064 (53.59%)

Average Assets

$20,613,202 (116.36%)

$9,527,330 (-39.00%)

$15,618,872 (-33.11%)

$23,350,662 (53.96%)

Invested Capital Average

$1,946,784 (138.96%)

$814,689 (228.99%)

-$631,602 (36.67%)

-$997,285 (-127.90%)

Shares

5,277,796 (-64.50%)

14,866,400 (15.64%)

12,855,735 (2.11%)

12,590,612 (9.94%)